Releases
GLMD
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Galmed Pharma (GLMD) stock and general news. This information may help you make smarter investment decisions.
About GLMD
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
More